MohrJ., PedersonJ., LongH.Leucocyte survival in hemodialysis patients. Okla State Med Assoc1982; 75: 114–7.
4.
AbrutynE., SolomonsN.W., St ClairL., MacGregorR.R., RootR.K.Granulocyte function in patients with chronic renal failure: surface adherence, phagocytosis, and bactericidal activity in vitro. J Inf Dis1977; 135: 1–8.
5.
KellyM.K., BrownJ.M., ThonyY.H.Neutrophil and monocyte adherence in diabetes mellitus, alcoholic cirrhosis, uremia, and elderly patients. Int Arch Allergy Appl Immun1985; 78: 132–8.
6.
BriggsW., PedersenM.M., MahajanS.K.Lymphocyte and granulocyte function in zinc-treated and zinc-deficient hemodialysis patients. Kidney Int1982; 21: 827–32.
7.
BriggsW., SillixD., MahajanS., McDonaldF.Leukocyte metabolism and function in uremia. Kidney Int1983; 24(suppl 16): S93–S96.
8.
RitcheyE., WallinJ., ShahS.Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int1981; 19: 349–58.
9.
RheeM., McGoldrickM.D., MeuwissenH.Serum factor from patients with chronic renal failure enhances polymorphonuclear leukocyte oxidative metabolism. Nephron1986; 42: 6–13.
10.
TumaS., MartinR., MallettL., EknoyanG.Augmented polymorphonuclear chemiluminescence in patients with secondary hyperparathyroidism. J Lab Clin Med1981; 97: 291–8.
11.
HeidlandA., HorlW.H., HellerN.Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. Kidney Int1983; 24(suppl 16): S27–S36.
12.
NelsonJ., OrmrodD.J., MillerT.E.Host immune status in uremia. VI. Leukocytic response to bacterial infection in chronic renal failure. Nephron1985; 39: 21–5.
13.
NelsonJ., OrmrodD.J., MillerT.E.Host immune status in uremia. IV. Phagocytosis and inflammatory response in vivo. Kidney Int1983; 23: 312–9.
14.
ClarkeI., OrmrodD., MillerT.E.Host immune response in uremia. V. Effect of uremia on resistance to bacterial infection. Kidney Int1983; 24: 66–73.
15.
PrestonC.J., NoorwaliA., ChallaA.Intracellular inorganic phosphate and ATP levels in human blood erythrocytes, leucocytes and platelets in normal subjects and in diseases associated with altered phosphate metabolism. Adv Exp Med Biology1982; 151: 147–55.
16.
MansellM.A., GrimesA.J., JonesN.F.Leukocyte ATP and renal failure. Clin Sci1981; 61: 43–6.
17.
MooradianA.D., MorleyJ.E., LevineA.S.The effects of chronic renal failure and hemodialysis on human red and white cell calmodulin levels. J Clin Endo Metab1984; 58: 1010–3.
18.
DeBariV., FrankO., BakerH., NeedleM.Water soluble vitamins in granulocytes, erythrocytes, and plasma obtained from chronic hemodialysis patients. Am J Clin Nutr1984; 39: 410–5.
19.
CasciatoD., McAdamL.P., KoppleJ.D.Immunologic abnormalities in hemodialysis patients: improvement after pyridoxine therapy. Nephron1981; 38: 9–16.
20.
VlahoM., SieberthH.Urea cycle and protein content in leucocytes from normal persons and uraemics. Proc. EDTA1981; 18: 638–41.
21.
MetcoffJ., DuttaS., BurnsG.Effects of amino acid infusions on cell metabolism in hemodialyzed patients with uremia. Kidney Int1983; 24(suppl 16): S87–S92.
22.
SpagnuoloP., BassS., SmithM., DanviriyasupK., DunnM.Neutrophil adhesiveness during prostacyclin and heparin hemodialysis. Blood1982; 60(4): 924–9.
23.
CohenM., ElliottD., ChaplinskiT., PikeM., NiedelJ.A defect in the oxidative metabolism of human leukocytes that remain in circulation early in hemodialysis. Blood1982; 60(6): 1283–9.
